Updates on COVID-19 (including visitor restrictions and mask requirements), monkeypox and flu. See Communicable Disease Updates

Your browser is out-of-date!

Internet Explorer 11 has been retired by Microsoft as of June 15, 2022. To get the best experience on this website, we recommend using a modern browser, such as Safari, Chrome or Edge.

×

Scripps Expert Calls Weight Loss Drug a “Game Changer”

Media interviews look at newly approved Wegovy

A physician measures a patient's waist circumference with a measuring tape.

Media interviews look at newly approved Wegovy

A new weight loss drug that uses a synthetic hormone to curb appetite promises to be a “game changer” in the battle against obesity, said Scripps Ken Fujioka, MD, director of nutrition and metabolic research at Scripps Clinic, during a recent media interviews.


Wegovy was approved in early June for use in the United States for weight loss treatment by the federal Food and Drug Administration.

Watch Aug. 3 CBS 8 interview with Dr. Fujioka: FDA Approves New Prescription for Weight Loss


Watch June 21 CBS 8 interview with Dr. Fujioka: FDA Approves New Obesity Drug for Long-Term Weight Management

Media Contact

Keith Darce
858-678-7121